Solar stocks took a beating Monday after China cut its national incentives to install solar projects. Shares of solar panel manufacturers Canadian Solar Inc. (NASDAQ:CSIQ) fell as much as 14.5%, JinkoSolar Holding Co. (NYSE:JKS) dropped as much as 17%, and Daqo New Energy Corp (NYSE:DQ) fell as much as 31.3% while inverter manufacturer Enphase Energy Inc (NASDAQ:ENPH) fell up to 13.5%. By early afternoon, most major stocks in the solar industry were down double digits.
So whatThere were two pieces of China's solar ruling, one having to do with distributed generation (DG) and the other with utility-scale solar.
Image source: Getty Images.
On the DG side, China put a cap of 10 gigawatts (GW) for new solar projects in 2018, down from 19 GW installed in 2017. According to Asia Europe Clean Energy Advisory Co (AECEA), there may already be more than 10 GW of DG projects installed in China, so that could make it tough to build any projects in the second half of the year.
Top 5 Clean Energy Stocks To Watch Right Now: Univest Corporation of Pennsylvania(UVSP)
Advisors' Opinion:- [By Max Byerly]
Univest Co. of Pennsylvania (NASDAQ:UVSP) was downgraded by equities research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a report released on Wednesday.
- [By Stephan Byrd]
Univest Co. of Pennsylvania (NASDAQ:UVSP) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a report issued on Wednesday.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Univest Co. of Pennsylvania (UVSP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 5 Clean Energy Stocks To Watch Right Now: McDermott International, Inc.(MDR)
Advisors' Opinion:- [By Logan Wallace]
Comerica Bank boosted its stake in shares of McDermott International Inc (NYSE:MDR) by 2.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 300,448 shares of the oil and gas company’s stock after purchasing an additional 8,298 shares during the period. Comerica Bank’s holdings in McDermott International were worth $1,853,000 at the end of the most recent quarter.
- [By Lisa Levin]
Breaking news
Hasbro, Inc. (NASDAQ: HAS) reported weaker-than-expected results for its first quarter on Monday. Subsea 7 S.A. confirmed a $7.00 per share proposal to acquire McDermott International Inc (NYSE: MDR). CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren Corp (NYSE: VVC) for $72 per share in cash. Bank of Hawaii Corporation (NYSE: BOH) reported upbeat earnings for its first quarter. - [By Lisa Levin] Gainers Valeritas Holdings, Inc. (NASDAQ: VLRX) shares jumped 17 percent to $3.65. Cambium Learning Group, Inc. (NASDAQ: ABCD) shares rose 13.5 percent to $11.70. McDermott International, Inc. (NYSE: MDR) gained 11.6 percent to $6.75 after the UK-based offshore oil service company Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron Company. Nautilus, Inc. (NYSE: NLS) shares jumped 11.2 percent to $14.95. Nautilus is expected to release Q1 results on May 7, 2018. Craig-Hallum initiated coverage on Nautilus with a Buy rating and a $19.00 price target. GEE Group, Inc. (NYSE: JOB) shares gained 11 percent to $2.2199. Check-Cap Ltd. (NASDAQ: CHEK) surged 10.8 percent to $4.50. Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) rose 10.1 percent to $3.39. Stars Group Inc. (NASDAQ: TSG) climbed 9.6 percent to $32.10. Stars Group Inc (NASDAQ: TSG) announced plans to acquire Sky Betting & Gaming for $4.7 billion. Insmed Incorporated (NASDAQ: INSM) shares jumped 9.1 percent to $25.66. Credit Suisse upgraded Insmed from Neutral to Outperform. Tennant Company (NYSE: TNC) rose 8.4 percent to $75.65 after the company posted upbeat Q1 results and raised its FY18 earnings outlook. Command Security Corporation (NYSE: MOC) shares gained 6.4 percent to $3.0960 after the company disclosed a $23 million five-year contract with LaGuardia Gateway Partners for LaGuardia Airport New Central Terminal Building. Helios and Matheson Analytics Inc. (NASDAQ: HMNY) rose 6.2 percent to $2.41 after falling 10.98 percent on Friday. Vectren Corporation (NYSE: VVC) shares rose 5.7 percent to $69.31. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash. Hanesbrands Inc. (NYSE: HBI) gained 4.9 percent to $18.035. Stifel Nicolaus upgraded Hanesbrands from Hold to Buy. M
- [By Sarah Priestley]
McDermott International (NYSE:MDR). They're in the process of buying Chicago Bridge & Iron (NYSE:CBI). They are possibly a little overvalued right now, but they are a big project company. They've been struggling recently with a lack of spending in energy and mining, which we've seen across the board with energy. That should be starting to shake out now.
Top 5 Clean Energy Stocks To Watch Right Now: Foamix Pharmaceuticals Ltd.(FOMX)
Advisors' Opinion:- [By Chris Lange]
Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) shares were last seen up early on Wednesday after the company announced a solid performance in its late-stage trial for moderate-to-severe acne.
- [By Joseph Griffin]
Foamix Pharmaceuticals (NASDAQ:FOMX)‘s stock had its “buy” rating reiterated by HC Wainwright in a report issued on Wednesday, MarketBeat reports. They currently have a $14.00 price objective on the specialty pharmaceutical company’s stock, up from their prior price objective of $12.00. HC Wainwright’s price objective would indicate a potential upside of 122.22% from the stock’s current price.
- [By Joseph Griffin]
Headlines about Foamix Pharmaceuticals (NASDAQ:FOMX) have been trending somewhat positive recently, according to Accern. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Foamix Pharmaceuticals earned a media sentiment score of 0.15 on Accern’s scale. Accern also gave news headlines about the specialty pharmaceutical company an impact score of 47.5479155329096 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
- [By Max Byerly]
HC Wainwright set a $11.00 price target on Foamix Pharmaceuticals (NASDAQ:FOMX) in a research note released on Tuesday. The firm currently has a buy rating on the specialty pharmaceutical company’s stock.
- [By Ethan Ryder]
News headlines about Foamix Pharmaceuticals (NASDAQ:FOMX) have trended somewhat positive recently, Accern reports. Accern rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Foamix Pharmaceuticals earned a news impact score of 0.15 on Accern’s scale. Accern also assigned press coverage about the specialty pharmaceutical company an impact score of 48.1562748121044 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
- [By Stephan Byrd]
Press coverage about Foamix Pharmaceuticals (NASDAQ:FOMX) has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Foamix Pharmaceuticals earned a news impact score of 0.14 on Accern’s scale. Accern also assigned press coverage about the specialty pharmaceutical company an impact score of 45.4298608245084 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Top 5 Clean Energy Stocks To Watch Right Now: New York Community Bancorp, Inc.(NYCB)
Advisors' Opinion:- [By Max Byerly]
Shares of New York Community Bancorp, Inc. (NYSE:NYCB) have been assigned a consensus recommendation of “Hold” from the sixteen research firms that are presently covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $12.25.
- [By Max Byerly]
Private Capital Group LLC grew its stake in New York Community Bancorp, Inc. (NYSE:NYCB) by 3,177.9% during the 1st quarter, HoldingsChannel reports. The fund owned 17,504 shares of the financial services provider’s stock after purchasing an additional 16,970 shares during the quarter. Private Capital Group LLC’s holdings in New York Community Bancorp were worth $228,000 as of its most recent SEC filing.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on New York Community Bancorp (NYCB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Boston Advisors LLC grew its stake in shares of New York Community Bancorp, Inc. (NYSE:NYCB) by 48.2% in the second quarter, HoldingsChannel reports. The firm owned 383,480 shares of the financial services provider’s stock after purchasing an additional 124,757 shares during the period. Boston Advisors LLC’s holdings in New York Community Bancorp were worth $4,234,000 as of its most recent SEC filing.
- [By Joseph Griffin]
Shares of NYSE:NYCB traded down $0.21 during midday trading on Tuesday, hitting $12.48. 4,058,407 shares of the company’s stock were exchanged, compared to its average volume of 4,950,782. The company has a debt-to-equity ratio of 2.05, a current ratio of 1.40 and a quick ratio of 1.40. The company has a market cap of $6,215.92, a PE ratio of 15.41, a PEG ratio of 1.48 and a beta of 0.65. New York Community Bank has a 12 month low of $11.67 and a 12 month high of $14.53.
ILLEGAL ACTIVITY NOTICE: “$0.20 EPS Expected for New York Community Bank (NYCB) This Quarter” was posted by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another site, it was stolen and reposted in violation of US and international copyright and trademark laws. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3365483/0-20-eps-expected-for-new-york-community-bank-nycb-this-quarter.html.New York Community Bank Company Profile
Top 5 Clean Energy Stocks To Watch Right Now: Trinity Biotech plc(TRIB)
Advisors' Opinion:- [By Max Byerly]
Trinity Biotech (NASDAQ: TRIB) is one of 25 publicly-traded companies in the “Diagnostic substances” industry, but how does it weigh in compared to its peers? We will compare Trinity Biotech to related businesses based on the strength of its analyst recommendations, valuation, risk, earnings, dividends, profitability and institutional ownership.
- [By Ethan Ryder]
Trinity Biotech (NASDAQ: TRIB) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations.
No comments:
Post a Comment